Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome

Stock Information for Trevena Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Trevena Inc.

Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting
Trevena Awarded OLINVYK Agreement with Premier, Inc.
Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries
Trevena Reports Third Quarter 2023 Results and Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.